proline has been researched along with Tauopathies in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 16 (84.21) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Ke, D; Li, HL; Li, L; Liu, R; Mahaman, YAR; Wang, JZ; Wang, Q; Wang, X; Wu, G; Zhang, B | 1 |
| Beaver, JD; Diamond, MI; Gupta, A; Hitt, BD; Joachimiak, LA; Shang, P; Singh, R; White, CL; Yang, T | 1 |
| Antón-Fernández, A; Avila, J; DeFelipe, J; Hernández, F; Merchán-Rubira, J; Muñoz, A | 1 |
| Anglada-Huguet, M; Joseph, M; Mandelkow, E; Mandelkow, EM; Paesler, K | 1 |
| Ceballos, C; Dickson, DW; Hyman, BT; Lin, WL; Polydoro, M; Ren, Y; Sahara, N; Sanchez, L; Spires-Jones, TL | 1 |
| Arena, J; Hitt, D; Koliatsos, VE; Marsh-Armstrong, N; Nguyen, JV; Rha, E; Ryu, J; Vranis, P; Xu, L | 1 |
| Cohen, TJ; Constance, BH; Hwang, AW; James, M; Yuan, CX | 1 |
| Berg, N; Coleman, M; Crowther, RA; Gasparini, L; Goedert, M; Martin, KR; Spillantini, MG | 1 |
| Cattepoel, S; Eckert, A; Kuehnle, K; Kulic, L; Nitsch, RM; Pagani, L; Rhein, V; Tracy, J; Wollmer, MA | 1 |
| Alleva, E; Calamandrei, G; Gasparini, L; Goedert, M; Scattoni, ML; Spillantini, MG | 1 |
| Mandelkow, EM; Sydow, A | 1 |
| Bista, P; Götz, J; Köhler, C; Schröder, H | 1 |
| Bilican, B; Chandran, S; Goedert, M; Hampton, DW; Spillantini, MG; Webber, DJ | 1 |
| Adamowicz, DH; Carlson, GA; Fox, LM; Hyman, BT; Pitstick, R; Spires-Jones, TL; William, CM | 1 |
| Iovino, M; Spillantini, MG; Vuono, R | 1 |
| Chen, A; Diaz-Ruiz, C; Ho, L; Ksiezak-Reding, H; Pasinetti, GM; Santa-Maria, I; Wang, J | 1 |
| Ando, K; Bégard, S; Bélarbi, K; Blum, D; Bretteville, A; Buée, L; Caillet-Boudin, ML; Demey-Thomas, E; Dourlen, P; Drobecq, H; Eddarkaoui, S; Galas, MC; Ghestem, A; Hamdane, M; Landrieu, I; Lippens, G; Maurage, CA; Melnyk, P; Sambo, AV; Sergeant, N; Smet, C; Verdier, Y; Vingtdeux, V; Vinh, J | 1 |
| Britschgi, M; Johns, H; Masliah, E; Rockenstein, E; Takeda-Uchimura, Y; Wyss-Coray, T | 1 |
| George-Hyslop, PS; Hagiwara, H; Ikeda, M; Kawarabayashi, T; Matsubara, E; Murakami, T; Nakazato, Y; Sasaki, A; Shoji, M; Westaway, D | 1 |
19 other study(ies) available for proline and Tauopathies
| Article | Year |
|---|---|
Phosphorylation of Truncated Tau Promotes Abnormal Native Tau Pathology and Neurodegeneration.
Topics: Alzheimer Disease; Animals; Mice; Mice, Inbred C57BL; Phosphorylation; Proline; tau Proteins; Tauopathies | 2022 |
Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds.
Topics: Alzheimer Disease; Antibodies, Monoclonal; Brain; Epitopes; Humans; Pick Disease of the Brain; Proline; tau Proteins; Tauopathies | 2023 |
Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
Topics: Animals; Carrier Proteins; Cerebral Cortex; Disease Models, Animal; Golgi Apparatus; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Transgenic; Neurofibrillary Tangles; Phosphopyruvate Hydratase; Phosphorylation; Proline; Pyramidal Cells; Receptors, Fibroblast Growth Factor; Serine; Sialoglycoproteins; tau Proteins; Tauopathies | 2017 |
Anti-aggregant tau mutant promotes neurogenesis.
Topics: Amino Acid Motifs; Animals; Astrocytes; Hippocampus; Humans; Mice; Mice, Transgenic; Microglia; Mutant Proteins; Neural Stem Cells; Neurogenesis; Proline; Protein Aggregation, Pathological; Protein Conformation; Protein Conformation, beta-Strand; Protein Domains; Repetitive Sequences, Amino Acid; tau Proteins; Tauopathies | 2017 |
Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
Topics: Analysis of Variance; Animals; Antibodies; Brain; Disease Models, Animal; Gene Expression Regulation; Humans; Leucine; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Molecular Weight; Mutation; Oligodendroglia; Proline; Rats; tau Proteins; Tauopathies | 2014 |
Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury.
Topics: Analysis of Variance; Animals; Brain Injuries; Cell Count; Cerebral Cortex; Disease Models, Animal; gamma-Synuclein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Proline; Pyramidal Tracts; Retina; Retinal Ganglion Cells; Serine; tau Proteins; Tauopathies; Visual Pathways | 2015 |
Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation.
Topics: Acetylation; Alzheimer Disease; Antibodies; Brain; Calpain; Catalysis; Humans; Lysine; Mass Spectrometry; Microtubules; Phosphorylation; Proline; Protein Binding; Protein Domains; Protein Isoforms; Protein Processing, Post-Translational; Proteolysis; Recombinant Proteins; tau Proteins; Tauopathies | 2016 |
Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.
Topics: Analysis of Variance; Animals; Axons; Bacterial Proteins; Disease Models, Animal; Humans; Inclusion Bodies; Intercellular Signaling Peptides and Proteins; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Mutation; Nerve Tissue Proteins; Neurofilament Proteins; Ophthalmoscopy; Organ Culture Techniques; Phosphorylation; Proline; Retinal Ganglion Cells; Serine; tau Proteins; Tauopathies | 2011 |
Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Topics: Adenosine Triphosphate; Age Factors; Animals; Apoptosis; Apoptosis Inducing Factor; Brain; Caspase 3; Electron Transport Complex I; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; In Situ Nick-End Labeling; Leucine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Mitochondria; Mitochondrial Diseases; Movement Disorders; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Oxidative Stress; Proline; Proton Pumps; Silver Staining; Statistics, Nonparametric; tau Proteins; Tauopathies | 2011 |
Early behavioural markers of disease in P301S tau transgenic mice.
Topics: Age Factors; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain; Cues; Disease Models, Animal; Exploratory Behavior; Humans; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Proline; Rotarod Performance Test; Serine; Spinal Cord; tau Proteins; Tauopathies; Visual Perception; Vocalization, Animal | 2010 |
'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
Topics: Age Factors; Animals; Brain; Disease Models, Animal; Doxycycline; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Mutation; Proline; Protein Structure, Tertiary; tau Proteins; Tauopathies | 2010 |
Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Topics: Animals; Basigin; Brain; Choline O-Acetyltransferase; Cholinergic Agents; Gene Expression Regulation; Interneurons; Leucine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Proline; tau Proteins; Tauopathies | 2010 |
Cell-mediated neuroprotection in a mouse model of human tauopathy.
Topics: Age Factors; Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cell Transplantation; Cell- and Tissue-Based Therapy; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Green Fluorescent Proteins; Homeodomain Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Growth Factor; Nerve Tissue Proteins; Neurons; Oligodendrocyte Transcription Factor 2; Proline; RNA, Messenger; Serine; Stem Cells; tau Proteins; Tauopathies | 2010 |
Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
Topics: Animals; Animals, Genetically Modified; Cell Count; Cytoskeletal Proteins; Disease Models, Animal; Doxycycline; Environment; Gene Expression Regulation; Hippocampus; Indoles; Leucine; Mice; Mutation; Nerve Tissue Proteins; Neurofibrillary Tangles; Neurons; Proline; RNA, Messenger; tau Proteins; Tauopathies | 2011 |
Release of growth factors by neuronal precursor cells as a treatment for diseases with tau pathology.
Topics: Analysis of Variance; Animals; Brain-Derived Neurotrophic Factor; Cell Differentiation; Disease Models, Animal; Female; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neural Stem Cells; Phosphorylation; Proline; Serine; Stem Cell Transplantation; tau Proteins; Tauopathies; Time Factors | 2011 |
GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.
Topics: Analysis of Variance; Animals; Antioxidants; Brain; Disease Models, Animal; Grape Seed Extract; Humans; Leucine; Male; Mice; Mice, Transgenic; Molecular Weight; Mutation; Polyphenols; Proline; Psychomotor Performance; Spinal Cord; tau Proteins; Tauopathies | 2012 |
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Animals; Biomarkers; Brain; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; Middle Aged; NIMA-Interacting Peptidylprolyl Isomerase; Oxidation-Reduction; Peptidylprolyl Isomerase; Phosphorylation; Proline; Protein Processing, Post-Translational; Proteome; Serine; tau Proteins; Tauopathies | 2013 |
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.
Topics: Animals; Brain; CD59 Antigens; Disease Models, Animal; Green Fluorescent Proteins; Humans; Leucine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Phosphorylation; Proline; Receptors, Complement; Signal Transduction; tau Proteins; Tauopathies | 2012 |
Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
Topics: Age Factors; Aged; Aged, 80 and over; Animals; Brain; Calcium-Binding Proteins; DNA-Binding Proteins; Female; Histocompatibility Antigens Class II; Humans; Leucine; Male; Mice; Mice, Transgenic; Microfilament Proteins; Microglia; Microscopy, Electron, Transmission; Middle Aged; Mutation; Proline; Receptors, Scavenger; tau Proteins; Tauopathies | 2008 |